Q3 2024 Holdings
Filed 2024-10-30 | 231 holdings | $134.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Rithm Capital Corp(RITM) | COM NEW | 64828T201 | $4.3M | 380,966 | 3.2% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $3.9M | 97,000 | 2.9% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $3.1M | 108,500 | 2.3% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $2.7M | 24,000 | 2.0% |
| Ellington Financial Inc(EFC) | COM | 28852N109 | $2.6M | 201,602 | 1.9% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $2.6M | 22,500 | 1.9% |
| Mgic Invt Corp WIS(MTG) | COM | 552848103 | $2.5M | 99,379 | 1.9% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $2.4M | 4,500 | 1.8% |
| Indivior PLC(INDV) | ORD | G4766E116 | $2.4M | 242,500 | 1.8% |
| Dynex Cap Inc(DX) | COM | 26817Q886 | $2.3M | 181,492 | 1.7% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $2.3M | 32,500 | 1.7% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $2.2M | 18,000 | 1.7% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $2.2M | 201,500 | 1.7% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $2.2M | 6,250 | 1.7% |
| Redwood Trust Inc(RWT) | COM | 758075402 | $2.2M | 288,343 | 1.7% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $2.2M | 205,000 | 1.6% |
| MFA Finl Inc(MFA) | COM | 55272X607 | $2.1M | 167,725 | 1.6% |
| Alphatec Hldgs Inc(ATEC) | COM NEW | 02081G201 | $2.1M | 370,000 | 1.5% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $2.0M | 30,000 | 1.5% |
| Invesco QQQ TR(QQQ) | UNIT SER 1 | 46090E103 | $2.0M | 4,182 | 1.5% |
| Invesco Exch Traded FD TR II(QQQM) | NASDAQ 100 ETF | 46138G649 | $2.0M | 10,158 | 1.5% |
| Royalty Pharma PLC(RPRX) | SHS CLASS A | G7709Q104 | $1.9M | 67,500 | 1.4% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $1.8M | 45,000 | 1.3% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $1.7M | 15,500 | 1.3% |
| AG MTG Invt TR Inc(MITT) | COM NEW | 001228501 | $1.6M | 208,879 | 1.2% |
| Enact Hldgs Inc(ACT) | COM | 29249E109 | $1.5M | 42,367 | 1.1% |
| Equity Lifestyle Pptys Inc(ELS) | COM | 29472R108 | $1.5M | 20,611 | 1.1% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $1.5M | 20,000 | 1.1% |
| Amphastar Pharmaceuticals in(AMPH) | COM | 03209R103 | $1.5M | 30,000 | 1.1% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $1.4M | 50,000 | 1.1% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $1.4M | 35,000 | 1.1% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $1.4M | 47,500 | 1.0% |
| New York MTG TR Inc(ADAM) | COM | 649604840 | $1.3M | 200,963 | 0.9% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $1.3M | 245,000 | 0.9% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $1.2M | 5,500 | 0.9% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $1.2M | 600,000 | 0.9% |
| Enovis Corporation(ENOV) | COM | 194014502 | $1.2M | 27,500 | 0.9% |
| Two Harbors Inventment Corpo | NOTE 6.250% 1/1 | 90187BAB7 | $1.2M | 1,205,000 | 0.9% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $1.2M | 100,000 | 0.9% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $1.1M | 26,000 | 0.8% |
| Takeda Pharmaceutical Co LTD(TAK) | SPONSORED ADS | 874060205 | $1.1M | 80,000 | 0.8% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $1.1M | 25,000 | 0.8% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $1.1M | 80,000 | 0.8% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $1.0M | 30,000 | 0.8% |
| Pfizer Inc(PFE) | COM | 717081103 | $1.0M | 35,000 | 0.8% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $1.0M | 17,500 | 0.7% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $997.9K | 35,000 | 0.7% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $987.8K | 9,000 | 0.7% |
| Pennymac Corp | NOTE 5.500%11/0 | 70932AAD5 | $961.4K | 965,000 | 0.7% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $943.6K | 10,500 | 0.7% |